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Abstract
Objective: Cardiopulmonary bypass (CPB) surgery induces a transient rise in pro-in¯ammatory cytokines typically released by activated
monocytes. The E4 variant of apolipoprotein E is a recognized risk factor for atherosclerosis. It has recently been shown that apolipoprotein E
affects monocyte functions in vitro and leads to higher levels of median lipoprotein (a) in humans. The aim of the study is to investigate if the
E4 genetic variant of apolipoprotein E affects cytokine release after CPB surgery. Methods: 22 patients were operated on with standard
coronary artery bypass grafting. Concentrations of interleukin 8 (IL-8) and tumor necrosis factor (TNF-a) were measured by automated
Immulite immunoassay at regular intervals within 48 h after surgery. Total apparent cytokine outputs were calculated as area under the curve.
Results are expressed as mean ^ standard deviation and compared by unpaired t-test. Results: In the presented patient population 6 (27%)
carried the E4 allele. Sixteen (63%) showed no E4 allele. Mean cross clamp time (CCT) was 56.2 ^ 13.5 min versus 55.7 ^ 12.1 min and
CPB time was 91.8 ^ 17.5 versus 93.5 ^ 15.7 min. No statistical difference between E4-carriers and E4 non-carriers regarding CCT and
CPB was observed. The total amount of IL-8 and TNF-a was higher in patients carrying the E4 genetic variant of apolipoprotein E in
comparison to E4 non-carriers (P , 0:08, P , 0:039). Conclusion: The presence of the E4 allele is associated with increased release of IL-8
and TNF-a after CBP surgery. The preoperative determination of E4 in patients undergoing cardiac surgery may lead to additional
perioperative measures for the treatment of an increased systemic in¯ammatory response. q 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
While in 1989 13% of our patients admitted for myocar-
dial revascularisation were 70±80 years old, 10 years later
(in 1999) this age group represented 28% of our coronary
artery bypass (CAB) population. From this shift towards
older patients, one may expect that a standard CAB patient
is much more prone to be multi-morbid, being on dialysis
due to renal insuf®ciency, restricted to low level exercise
due to decreased lung function and showing signs of a
progressed general arteriosclerosis.
In order to optimise the anesthetic and surgical manage-
ment in time the operative risk of a patient has to be indi-
vidually determinate, to make the surgical procedure as safe
as possible. Besides known risk factors for arteriosclerosis
like hypertension, smoking, hypercholesterolemia, there
may be some other factors responsible for the outcome of
patients. The individual way a body is coping with situations
such as low oxygen content (cardiac tissue under cardiac
arrest), or a systemic infection, for example, might be even
determined by polymorphic genes.
The apolipoprotein E (ApoE) is a 34 kDa glycosylated
protein which plays a major role in the cholesterol metabo-
lism as a transport protein and is known to be anti-athero-
genic by redistribution of cholesterol from the arterial wall.
The apolipoprotein E gene is polymorphic: there are three
major alleles described in the literature (12, 13 and 14),
which differ by single amino acid exchanges at residues
112 and 158 (12: Cys112 Cys158; 13: Cys112Arg158; 14:
Arg112Arg158) [1] resulting in six different genotypes (12/2,
12/3, 12/4, 13/3, 13/4 and 14/4). The E4 variant of apolipo-
protein E is recognized as a risk factor for atherosclerosis and
correlates to the severity of coronary artery diseases [2±4].
This E4 protein increases the blood cholesterol concentration
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[5±8] which may lead to coronary artery wall lesions [9]. But
might the Apo E4 protein even play a role in acute cardiac
ischemia (e.g., during cardiac arrest intra-operatively)?
Cardiac ischemia leads to a release of pro-in¯ammatory
cytokines (TNF-a, IL-6, IL-8) which may be a major cause
for morbidity and mortality in the cardiac surgery patient
population. Clinical and experimental studies revealed that
pro-in¯ammatory cytokines may lead to myocardial
dysfunction based on an increase of adhesion-molecules
followed by invasion of leukocytes to the myocardium
and an increase of myocardial apoptosis [10].
The aim of the presented study is to investigate if the E4
genetic variant of apolipoprotein E is associated with a
higher pro-in¯ammatory cytokine (TNF-a, IL-6, IL-8)
release after by cardiopulmonary bypass (CPB) surgery
compared to the patient group without E4 genetic variants.
2. Material and methods
2.1. Patient groups
In a 6-month period from February to August 2000, 22
patients undergoing coronary artery bypass surgery were
selected for the presented study. Informed consent was
obtained from each patient according to the protocol of
the Ethics committee of the University Hospital ZuÈrich.
Patients with known infection, with known neoplasm,
previous coronary artery bypass surgery or inserted intra-
aortic-balloon-pump were excluded from the study.
2.2. Operative techniques
Cardiopulmonary bypass was performed using a StoÈckert
roller pump system (StoÈckert Intrumente GmbH Munich,
Germany) and a Shiley±Dideco Maxima hollow ®ber
oxygenator (Dideco, Mirandola, Italy). Cold cristalloid
Buckberg cardioplegia with an initial dose of 15 ml/kg
was applied for myocardial protection. Repeated infusions
of 300 ml were given every 20 min or earlier if electrical
activity occurred. Before aortic declamping 500 ml warm
blood cardioplegia (hot shot) was administered at 378C for 2
min at a pressure of 50 mmHg. Using the heat-exchange
oxygenator, warming blanket, and heated humidi®ed gases
to reach a rectal temperature of .348C before terminating
CPB, rewarming was achieved.
2.3. Blood sampling and analysis
For each patient 6 ml blood samples (lithium-heparinate
plasma) were obtained through a central venous catheter at
12 different time points. The ®rst sample was taken before
anesthesia, the second 0.5 h after re-opening of coronary
circulation (declamping the aorta), the third 1 h after re-
opening of coronary circulation, the fourth 2 h after re-open-
ing of coronary circulation, the ®fth 4 h after re-opening of
coronary circulation, the sixth 8 h after re-opening of coron-
ary circulation, the seventh 16 h after re-opening of coron-
ary circulation, the eighth 24 h after re-opening of coronary
circulation, the ninth 32 h after re-opening of coronary
circulation and the tenth 48 h after re-opening of coronary
circulation. At the ®rst time point an additional tube of
ethylenediaminetetra acid (EDTA) blood was drawn for
genotyping.
Concentration of IL-8 and TNF-a in lithium-heparin
anticoagulated plasma was determined by automated
enzyme-chemiluminescence immunoassay on an Immulite
I system (Diagnostics Product Corporation, Los Angeles
and Buehlmann Laboratories AG, Allschwil, Switzerland)
according to the instructions of the manufacturer [11]. For
genotyping of Apolipoprotein E, genomic DNA was
extracted from 200 ml of EDTA-anticoagulated blood by
the MagNA Pure LC and real time polymerase chain reac-
tion (PCR) was performed on a LightCycler (both from
Roche Diagnostics, Rotkreuz, Switzerland) with primers
and hybridisation probes synthesized by TIB MolBiol
(Berlin, Germany) according to Aslanidis et al. [12].
2.4. Clinical variables
Medical history and demographic data were collected
prospectively, as well as the postoperative course including
ICU stay, occurrence of myocardial infarction, arrhythmias,
bleeding, intubation time, pulmonary infections requiring
antibiotic treatment and length of hospital stay.
2.5. Statistical methods
Fischer's exact test and Student's t-test with mean and
standard deviations were used for comparisons of percen-
tages and means for normally distributed data. The Mann±
Whitney test was applied otherwise. P , 0:05 was consid-
ered statistically signi®cant.
3. Results
3.1. Patients
Of the 22 patients enrolled in this study, six patients
(27%) carried the E4 genetic variants of the apolipoprotein
E (®ve heterozygous E3±E4, one homozygous E4±E4) 16
patients (73%) carried no E4 genetic variants. Comparison
of the preoperative pro®le (age, sex, risk factors) of the E4-
carrier group versus the E4-non-carrier group demonstrated
no statistical differences (Table 1). The intra-operative
management confers that in the E4- carrier versus E4-non-
carrier CPB-time (93.5 ^ 15.7 min versus 91.8 ^ 17.5
min), aortic cross clamp time (55.7 ^ 12.1 versus
56.2 ^ 13.5 min), lowest body temperature on bypass
(32.2 ^ 2.7 versus 29.9 ^ 4.58C) and the number of
performed distal anastomoses (4.8 ^ 0,8 versus 4.1 ^ 1.3)
were not statistically signi®cant different (Table 1).
The postoperative data demonstrate that the intensive
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care unit and hospital stay did not differ between the groups.
E4-carriers developed slightly more cardiac arrhythmias
(right bundle branch block (RBBB); left bundle branch
block (LBBB) and atrio-ventricular block (AV-block) than
the E4-non-carrier (Table 1).
3.2. Cytokine release induced by cardiopulmonary bypass
surgery
3.2.1. TNF-a release in E4-non-carriers versus E4-carriers
In E4-carriers a signi®cant higher amount of TNF-a was
already found at the ®rst blood sampling (time 22:
P  0:03), before declamping the aorta (re-opening of the
coronary circulation) (time 0: P  0:01); 0.5 h (P  0:01); 1
h (P  0:01); 2 h (P  0:02); 4 h (P  0:04) and 24 h
(P  0:001) after declamping the aorta (Table 2). The high-
est levels of circulating TNF-a were found 4 h after re-
opening of the coronary circulation in both groups; mean
level was slightly higher in the E4-carrier group (17.1 ^ 5.7
versus 11.5 ^ 2.7) in the non-carrier group with no statisti-
cal signi®cance. The total apparent cytokine output of TNF-
a (area under curve) was signi®cantly higher in patients
carrying the E4 genetic variant of apolipoprotein E in
comparison to E4-non-carriers (663 ^ 306 pg/ml versus
361 ^ 107 pg/ml; P  0:039) (Table 2).
3.2.2. IL-8 release in E4-non-carriers versus E4-carriers
Highest levels of IL-8 were measured 4 h after reopening
of the coronary circulation (Table 3) in both groups
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Table 2
Expression of TNF-a in E4- and non- E4 carrier at different time pointsa
TNF-a (pg/ml)
Time (h) E4-non-carrier (n 16) E4-carrier (n 6) P value
0 5.3 ^ 2.0 8.6 ^ 3.8 NS
0.5 6.4 ^ 2.3 10.7 ^ 2.6 0.01
1 8.4 ^ 3.2 13.7 ^ 3.2 0.01
2 10.4 ^ 3.9 16.2 ^ 4.9 0.02
4 11.5 ^ 2.7 17.2 ^ 5.8 0.04
8 9.5 ^ 3.8 14.4 ^ 6.4 NS
16 7.9 ^ 4.1 11.5 ^ 6.6 NS
24 6.4 ^ 2.3 16.7 ^ 4.4 0.001
32 6.7 ^ 2.6 13.2 ^ 8.7 NS
48 6.5 ^ 2.8 12.3 ^ 10.7 NS
Total 361 ^ 107 663 ^ 306 0.039
a Total apparent release of TNF-a was calculated as area under curve
(AUC), results are expressed as mean ^ standard deviation.
Table 1
Demographics, risk factors, coronary artery diagnosis, intraoperative data and outcome: E4 carriers vs. E4-non-carriers
E4-non-carrier (n 16) n (%) E4-carrier (n 6) n (%) P value
Demographics
Age 65 ^ 8 63 ^ 7 NS
Sex (male/female) 15/1 4/2 NS
Risk factors
Diabetes type II 1 (6) 1 (17) NS
Hypertension 9 (56) 3 (50) NS
Hypercholesterolemia 15 (93) 6 (100) NS
Smoker 10 (63) 4 (67) NS
BMI 27.9 ^ 3.4 25.4 ^ 1.5 0.02
Family history 8 (50) 3 (50) NS
COPD 3 (19) 0 NS
Coronary diagnosis
3-KHK 10 (63) 5 (83) NS
2-KHK 6 (38) 1(17) NS
Myocardial infarct ,7d 0 0
Myocardial infarct .7d 7 (44) 2 (33) NS
EF (%) 63.4 ^ 11.7 67.8 ^ 4.7 NS
Operation
CPB time 91.8 ^ 17.5 93.5 ^ 15.7 NS
Ortic cross-clamp time 56.2 ^ 13.5 55.7 ^ 12.1 NS
Lowest temperature on bypass 29.9 ^ 4.5 32.2 ^ 2.7 NS
Number distal anastomosis 4.1 ^ 1.3 4.8 ^ 0.8 NS
Outcome
ICU stay 1.6 ^ 1.4 2.0 ^ 1.7 NS
Hospital stay 8.6 ^ 2.4 7.5 ^ 1.2 NS
Infarct 0 0
Arrhythmia
Atrial 5 (31) 0 NS
Ventricular 2 (12) 0 NS
Block (RBBB; LBBB; AV-block) 5 (31) 3 (50) NS
Pulmonary dysfunction 1 (6) 1(17) NS
Rethoracotomy 1 (6) 1 (17) NS
(35.3 ^ 13.0) in the E4-carrier group and 27.8 ^ 14.1 in the
E4-non-carrier group. IL-8 levels during the operation and
up to 32 h after declamping the aorta were always higher in
the E4-carriers, with statistical signi®cance at time-point 2 h
(P  0:04) and 32 h (P  0:02). The total apparent cytokine
output of IL-8 (area under curve) was higher in patients
carrying the E4 genetic variant of apolipoprotein E in
comparison to E4-non-carrier (876 ^ 400 pg/ml versus
589 ^ 201 pg/ml; P  0:088) (Table 3).
4. Discussion
Patients admitted for a standard CAB surgery are nowa-
days much more multi-morbid than 10 years ago. Improved
anesthetic and surgical management have let the surgeons
accept patients who would have been rejected due to a high
operative risk in regard to their age and end organ function
10 years ago. To further lower the individual operative risk
of patients, new factors have to be determined which might
in¯uence the postoperative course. We believe that poly-
morphic genes have the potential to play a role in the indi-
vidual response to stress situations like an oxygen shortage.
We examined quantitatively whether the E4 variant of
apolipoprotein E is connected with the release of pro-
in¯ammatory cytokines during and after CPB surgery.
In the presented study, 27% patients possessed the apo E4
genotype. Inbal et al. [13] found an Apo E 14 allele
frequency of 9.4% in young males with an acute myocardial
infarction versus 5.3% in the control group. In this study
patients with Apo E4 polymorphism had a nine-fold
increased estimated risk to develop an acute myocardial
infarction. This risk increased up to 18-fold, if the patient
was in addition a current smoker. Katzel et al. [14] demon-
strate, that healthy men with the Apo E4 allele were at
increased risk for exercise-induced silent ischemia.
Our results suggest that Apo E4 carriers show signi®cant
higher TNF-a levels during and after CAB surgery than
non-carriers (Fig. 1). Thus apolipoprotein E4 may regulate
the production and/or release of TNF-a at the DNA or a
receptor/second-messenger level.
In an isolated rat heart model ischemia induced local
release of TNF-a leads to a depression in myocardial
contractility and coronary ¯ow as well as to an increase in
end-diastolic pressure and creatine kinase production [10],
therefore E4 carrier might be at a higher risk to develop a
more severe myocardial dysfunction during coronary artery
bypass surgery.
It cannot, however, be excluded that the effect is caused
by another gene polymorphism in linkage disequilibria with
the Apo E4 genetic variant. In any case, our results warrant
con®rmation in a larger study.
In addition our patients with the Apo E4 allele had a
higher level of IL-8 during and up to 32 h after cardiac
surgery (Fig. 2). However, the aortic cross clamp and the
CPB time did not differ between groups, we suggest that
Apo E4 carriers might be more prone to myocardial cell
damage than the E4-non-carriers, or Apo E4 directly or
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Table 3
Expression of IL-8 in E4- and non-E4-carrier at different time pointsa
IL-8 (pg/ml)
Time (h) E4-non-carrier (n 16) E4-carrier (n 6) P value
0 6.6 ^ 4.2 8.3 ^ 5.6 NS
0.5 14.0 ^ 11.9 16.7 ^ 14.5 NS
1 14.4 ^ 9.0 20.5 ^ 15.4 NS
2 19.1 ^ 11.4 30.8 ^ 11.6 0.04
4 27.8 ^ 14.1 35.3 ^ 13.0 NS
8 18.7 ^ 13.4 29.5 ^ 11.5 NS
16 12.0 ^ 9.8 17.5 ^ 12.9 NS
24 10.7 ^ 3.5 20.5 ^ 21.5 NS
32 7.6 ^ 3.0 13.2 ^ 4.4 0.02
48 8.1 ^ 2.6 7.3 ^ 3.0 NS
Total 876 ^ 400 589 ^ 201 0.088
a Total apparent release of IL-8 within 48 h was calculated as area under
curve (AUC); results are expressed as mean ^ standard deviation.
Fig. 1. Means of TNF-a at different time points (green rectangle, E4-
carrier; red rhombus, E4-non-carrier).
Fig. 2. Means of IL-8 at different time points (green rectangle, E4-carrier;
red rhombus, E4-non-carrier).
indirectly stimulates IL-8 release unrelated to the extent of
injury.
While IL-8 also works as a potent activator of neutrophils
as well as of T-lymphocytes [15] when released from the
myocardium during ischemia, it is known that Apolipopro-
tein E also has the ability to suppress lymphocyte prolifera-
tion, generate cytolytic T-cells and stimulate cultured
neutrophils [1], effects could be exponentiated. De Bont
and co-workers also showed that Apo E 2 /2 mice are
more susceptible than control C57BL/6 mice to a Klebsiella
pneumoniae infection. The absence of Apo E may render
these mice more susceptible, since this protein is of impor-
tance in the detoxi®cation of lipopolysaccharide of Gram-
negative bacteria. On the other hand, the phagocytic capa-
city of granulocytes also seems to be decreased in Apo E 2 /
2 mice, resulting in increased mortality [16].
In conclusion patients carrying the apolipoprotein E4
allele variant can be identi®ed with a simple blood genotyp-
ing test, and the anesthetic and surgical management may be
individually changed in time. While we demonstrated that
these patients are prone to a higher TNF-a release during
and after CPB surgery, we suggest to consider additional
perioperative measures for the treatment of the increased
systemic in¯ammatory response, i.e. modi®ed ultra®ltration
(MUF), since GruÈnenfelder et al. [17] could show that circu-
lating cytokines like TNF-a and IL-8 can be ®ltered out of
the circulation by using modi®ed ultra®ltration. Periopera-
tive steroid application has also shown to lower cytokine
release after cardiopulmonary bypass [18]. The surgical
management has to be discussed once these results have
been con®rmed in a larger patient population.
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